Bruker Announces Partnership with GRAST at Chungnam National University in Korea to Develop Glycomics Reference Site
December 01 2011 - 6:00AM
Business Wire
Bruker Corporation and the Graduate School of Analytical Science
and Technology (GRAST) at Chungnam National University have
announced a collaboration to advance the field of Glycomics and its
applications in the rapidly growing biopharmaceutical industry in
the Republic of Korea. This collaboration adds to the growing
number of partnerships and industry linkage projects which Bruker
has fostered with the scientific communities of Asia Pacific.
Bruker ultrafleXtreme™ MALDI-TOF/TOF Mass
Spectrometer (Photo: Business Wire)
Under the collaboration agreement, the GRAST team, led by
Professor Hyun Joo An, and the Glycomics Applications Development
Group at Bruker, led by Dr Detlev Suckau will jointly develop
MALDI-TOF(/TOF) based methodologies targeting the analysis
of glycans. These studies will create a better understanding of the
function of glycans in biomolecules, and their key role in many
biological processes. The partners will target much of their
efforts towards the development of specific methods and software
applications that can be utilized in the development and quality
control (QC) of biosimilar pharmaceutical products, such as
therapeutic antibodies. In conjunction with industrial partners in
Korea and the Korea Basic Science Institute (KBSI) - already a key
Bruker collaborator and the operator of the region’s highest field
15 Tesla MALDI/ESI- FTMS system - the partnership will act
as an Asia Glycomics Reference Site (AGRS) and offer broader
analytical support to the wider Asian Glycomics community.
“My team at GRAST is delighted to be able to partner with Bruker
to develop our MALDI-TOF and other analytical approaches to
advance the field of Glycomics in Korea,” stated Professor Hyun Joo
An. “The potential we see, particularly for the biosimilar
industry, indicates that glycan research will continue to increase
in importance, particularly as workflows develop to unravel its
complexities.”
“We are proud to announce this collaboration with Bruker, and
will work closely together with them to develop cutting-edge
methodologies for Glycomics research,” added Dr. Kwang Hwa Chung,
Dean of GRAST at Chungnam National University.
“Development of meaningful and result-driven partnerships with
premier research teams in Asia Pacific has been a focus for Bruker
in recent years,” commented Clive Seymour, Bruker Daltonics
Executive Vice President for the Asia Pacific Region. “Our
technologies and workflows offer enormous potential to advance the
developing fields in Glycomics and particularly in its applications
in the biopharmaceutical area. Under the direction of Professor An
and her team at GRAST, we are confident the outcomes of this
partnership will help drive a rapidly growing research field in
Korea and beyond.”
About GRAST
GRAST is jointly established by Chungnam National University
(CNU) and Korea Basic Science Institute (KBSI), in an effort to
bring out the synergistic efforts in both education and research.
GRAST is the only graduate school in Korea structured in this
fashion. The curriculum offered at GRAST covers theory, principles
and the applications of analytical technologies in the fields of NT
(nanoscience technology), BT (bioscience technology), ET
(Environmental Science and Technology), and many other fusion
fields of study.
About Bruker Corporation
Bruker Corporation (NASDAQ: BRKR) is a leading provider of
high-performance scientific instruments and solutions for molecular
and materials research, as well as for industrial, clinical and
applied analysis . For more information on Bruker MALDI-TOF
systems and Bruker Daltonics, please visit www.bdal.com. For
information about Bruker Corporation (NASDAQ: BRKR), please visit
www.bruker.com.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50088761&lang=en
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024